Fig. 2From: Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease preventionTimescale of the recognition of metabolic dysfunction-associated fatty liver disease (MAFLD) amongst cardiovascular societiesBack to article page